NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
PA-25-147This grant opportunity is for high-risk, multi-center clinical trials that involve multiple clinical centers. The trials should be based on a hypothesis and aim to impact clinical practice or public health, focusing on a disease relevant to NIDDK's mission. Planning must be done before applying, as planning activities are not included in this grant. If planning is needed, applicants can first …
This NOFO invites applications for investigator-initiated, high-risk multi-center therapeutic clinical trials conducted at one or more clinical centers. A multi-center study is classified as “high risk” if it utilizes either a high-risk intervention or has high operational risk, or both. NOT-DK-…
Source
Eligibility
Foreign/Non-domestic entities are NOT eligible to apply. Specifically: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants…
Dates
Supporting links
Similar opportunities
-
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
-
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
-
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
-
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
-
Notice of Funding Opportunity (NOFO) for Investigator-Initiated Single Site Clinical Trials